HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 182 filers reported holding HERON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $134,406 | -91.8% | 89,280 | -65.1% | 0.00% | -66.7% |
| Q4 2022 | $1,645,402 | +542.7% | 256,055 | +323.0% | 0.00% | +200.0% |
| Q3 2022 | $256,000 | +77.8% | 60,532 | +17.0% | 0.00% | 0.0% |
| Q2 2022 | $144,000 | +1.4% | 51,722 | +108.1% | 0.00% | 0.0% |
| Q1 2022 | $142,000 | -31.7% | 24,852 | +9.1% | 0.00% | 0.0% |
| Q4 2021 | $208,000 | -9.6% | 22,788 | +5.8% | 0.00% | 0.0% |
| Q3 2021 | $230,000 | -31.1% | 21,545 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $334,000 | -4.3% | 21,545 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $349,000 | -13.6% | 21,545 | +12.9% | 0.00% | 0.0% |
| Q4 2020 | $404,000 | +43.3% | 19,082 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $282,000 | +28.8% | 19,082 | +28.3% | 0.00% | 0.0% |
| Q2 2020 | $219,000 | +46.0% | 14,876 | +16.8% | 0.00% | 0.0% |
| Q1 2020 | $150,000 | -41.9% | 12,741 | +15.9% | 0.00% | 0.0% |
| Q4 2019 | $258,000 | +26.5% | 10,997 | -0.1% | 0.00% | 0.0% |
| Q3 2019 | $204,000 | – | 11,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |